Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in the Prevention of Recurrent Pancreatitis
2024-513188-17-03Phase 4Completed
- Sponsor
- Hospital General Universitario de Alicante
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in pancreatitis comparing Simvastatin with Placebo (2 arms). Primary endpoint: Recurrence of pancreatitis. Started Sep 2024; status: completed.
02
Drugs
simvastatin
03
Conditions
pancreatitis
Beyond the preview
Go deeper on 2024-513188-17-03.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513188-17-03.